Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.130
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
2.060
-0.070 (-3.29%)
Pre-market: Jun 22, 2026, 6:57 AM EDT

Sunshine Biopharma Statistics

Total Valuation

SBFM has a market cap or net worth of $3.44 million. The enterprise value is -$2.72 million.

Market Cap3.44M
Enterprise Value -2.72M

Important Dates

The last earnings date was Wednesday, May 13, 2026, after market close.

Earnings Date May 13, 2026
Ex-Dividend Date n/a

Share Statistics

SBFM has 1.62 million shares outstanding. The number of shares has increased by 286.75% in one year.

Current Share Class 1.62M
Shares Outstanding 1.62M
Shares Change (YoY) +286.75%
Shares Change (QoQ) +1.10%
Owned by Insiders (%) 0.63%
Owned by Institutions (%) 2.72%
Float 1.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.10
Forward PS 0.13
PB Ratio 0.05
P/TBV Ratio 0.18
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.03.

Current Ratio 4.22
Quick Ratio 1.86
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -27.32% and return on invested capital (ROIC) is -12.47%.

Return on Equity (ROE) -27.32%
Return on Assets (ROA) -10.02%
Return on Invested Capital (ROIC) -12.47%
Return on Capital Employed (ROCE) -20.76%
Weighted Average Cost of Capital (WACC) 9.40%
Revenue Per Employee $709,866
Profits Per Employee -$120,789
Employee Count50
Asset Turnover 1.24
Inventory Turnover 1.90

Taxes

In the past 12 months, SBFM has paid $61,770 in taxes.

Income Tax 61,770
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -85.51% in the last 52 weeks. The beta is 1.31, so SBFM's price volatility has been higher than the market average.

Beta (5Y) 1.31
52-Week Price Change -85.51%
50-Day Moving Average 6.57
200-Day Moving Average 12.03
Relative Strength Index (RSI) 30.32
Average Volume (20 Days) 2,512,798

Short Selling Information

The latest short interest is 1.44 million, so 89.26% of the outstanding shares have been sold short.

Short Interest 1.44M
Short Previous Month 496,125
Short % of Shares Out 89.26%
Short % of Float 89.83%
Short Ratio (days to cover) 0.04

Income Statement

In the last 12 months, SBFM had revenue of $35.49 million and -$6.04 million in losses. Loss per share was -$12.83.

Revenue35.49M
Gross Profit 11.71M
Operating Income -4.58M
Pretax Income -5.98M
Net Income -6.04M
EBITDA -4.23M
EBIT -4.58M
Loss Per Share -$12.83
Full Income Statement

Balance Sheet

The company has $6.91 million in cash and $744,840 in debt, with a net cash position of $6.17 million or $3.82 per share.

Cash & Cash Equivalents 6.91M
Total Debt 744,840
Net Cash 6.17M
Net Cash Per Share $3.82
Equity (Book Value) 21.52M
Book Value Per Share 43.83
Working Capital 18.91M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.71 million and capital expenditures -$172,130, giving a free cash flow of -$5.88 million.

Operating Cash Flow -5.71M
Capital Expenditures -172,130
Depreciation & Amortization 344,136
Net Borrowing n/a
Free Cash Flow -5.88M
FCF Per Share -$3.64
Full Cash Flow Statement

Margins

Gross margin is 32.98%, with operating and profit margins of -12.90% and -17.02%.

Gross Margin 32.98%
Operating Margin -12.90%
Pretax Margin -16.84%
Profit Margin -17.02%
EBITDA Margin -11.93%
EBIT Margin -12.90%
FCF Margin n/a

Dividends & Yields

SBFM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -286.75%
Shareholder Yield -286.75%
Earnings Yield -175.39%
FCF Yield -170.77%

Analyst Forecast

The average price target for SBFM is $56.00, which is 2,529.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target $56.00
Price Target Difference 2,529.11%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on June 1, 2026. It was a reverse split with a ratio of 1:10.

Last Split Date Jun 1, 2026
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 3